Clinical trials: Prostate-Specific Antigen
Urologic Cancer, Biochemical Recurrence of Malignant Neoplasm of Prostate
SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy
To evaluate the efficacy and safety of a pembrolizumab therapy of pembrolizumab in combination with standard salvage radiation therapy (SRT) in patients with biochemical recurrence (BCR) of prostate-specific antigen (PSA)…
- Trial name
- Pembro-SRT (NCT04931979)
- Testing
- Pembrolizumab Injection [Keytruda], Salvage Radiation Therapy (SRT)
- Where
- Germany
- Volunteers
- 49 people
- Sponsor
- Prof. Dr. med. Christian Gratzke